HIF1A and cancer: This concept is supported by previous studies showing that Akt acts as an upstream mediator of HIF-1α activation in cancer cells [53] and PASMCs [13,14,15,16], leading ultimately to increased cell survival, proliferation, and a glycolytic switch.